Beck Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Beck Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,895	Closed	-$342K	–	136
2015 Q4	$342K	Hold	4,895	–	–	0.2%	89
2015 Q3	$327K	Sell	4,895 -450	-8%	-$35K	0.23%	78
2015 Q2	$419K	Hold	5,345	–	–	0.22%	93
2015 Q1	$408K	Hold	5,345	–	–	0.23%	94
2014 Q4	$356K	Sell	5,345 -55	-1%	-$3.66K	0.21%	107
2014 Q3	$341K	Sell	5,400 -380	-7%	-$23.5K	0.24%	110
2014 Q2	$353K	Buy	5,780 +610	+12%	+$35.4K	0.23%	107
2014 Q1	$295K	Buy	+5,170	New	+$294K	0.23%	117

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Beck Capital Management's PJP Position: Q1 2016 in Review

Beck Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2016, closing a stake of 4,895 shares — an estimated $342K sold.

Beck Capital Management first reported a position in PJP in Q1 2014 and held it in 8 quarters. The position peaked at $419K in Q2 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

Beck Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Beck Capital Management sold 4,895 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $342K.
Beck Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2014 and held it in 8 quarters.
Beck Capital Management's Invesco Pharmaceuticals ETF position peaked at $419K in Q2 2015.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on Beck Capital Management's 13F filing for Q1 2016, filed 13 May 2016.